Precigen, Inc. Share Based Compensation of Revenue

Share Based Compensation of Revenue of PGEN for past 10 years: annual, quarterly and twelve month trailing (TTM) including Share Based Compensation of Revenue growth rates and interactive chart.


Highlights and Quick Summary

  • Share Based Compensation of Revenue for the quarter ending June 30, 2022 was 79.32% (a 513.93% increase compared to previous quarter)
  • Year-over-year quarterly Share Based Compensation of Revenue increased by 586.75%
  • Annual Share Based Compensation of Revenue for 2021 was 13.94% (a -25.77% decrease from previous year)
  • Annual Share Based Compensation of Revenue for 2020 was 18.78% (a -42.04% decrease from previous year)
  • Annual Share Based Compensation of Revenue for 2019 was 32.4% (a 4.25% increase from previous year)
  • Twelve month Share Based Compensation of Revenue ending June 30, 2022 was 14.1% (a 24.34% increase compared to previous quarter)
  • Twelve month trailing Share Based Compensation of Revenue decreased by -15.62% year-over-year
Trailing Share Based Compensation of Revenue for the last four month:
30 Jun '22 31 Mar '22 31 Dec '21 30 Sep '21
14.1% 11.34% 13.94% 16.71%
Visit stockrow.com/PGEN for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Share Based Compensation of Revenue of Precigen, Inc.

Most recent Share Based Compensation of Revenueof PGEN including historical data for past 10 years.

Interactive Chart of Share Based Compensation of Revenue of Precigen, Inc.

Precigen, Inc. Share Based Compensation of Revenue for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 79.32% 12.92%
2021 10.08% 11.55% 10.59% 24.45% 13.94%
2020 23.26% 19.83% 16.1% 17.77% 18.78%
2019 40.41% 42.2% 14.98% 43.77% 32.4%
2018 30.33% 34.05% 25.16% 36.06% 31.08%
2017 18.85% 32.13% 27.18% 20.11% 22.81%
2016 30.57% 27.33% 17.63% 37.46% 27.75%
2015 33.33% 15.71% 17.55% 31.73% 23.52%
2014 22.44% 20.05% 58.61% 53.48% 31.05%
2013 15.46% 10.92% 13.36% 9.96% 12.82%
2012 15.32% 21.86% 11.26%
2011 12.38%

Business Profile of Precigen, Inc.

Sector: Healthcare
Industry: Biotechnology